PMID- 36553522 OWN - NLM STAT- MEDLINE DCOM- 20230103 LR - 20230109 IS - 2073-4425 (Electronic) IS - 2073-4425 (Linking) VI - 13 IP - 12 DP - 2022 Nov 30 TI - Novel Insights into MEG3/miR664a-3p/ADH4 Axis and Its Possible Role in Hepatocellular Carcinoma from an in Silico Perspective. LID - 10.3390/genes13122254 [doi] LID - 2254 AB - Hepatocellular carcinoma (HCC) is a complex disease involving altered interactomes of transcripts and proteins. MicroRNAs (miRNAs) are small-noncoding RNAs that can interact with specific gene transcripts and an array of other vital endogenous non-coding RNAs (lncRNAs) that can influence gene expression. Maternally Expressed Gene 3 (MEG3) is an imprinted lncRNA that is reported to be downregulated in HCC (in both cell lines and tumors). Alcohol Dehydrogenase 4 (ADH4) is a well-known prognostic protein biomarker for predicting the survival outcomes of patients with hepatocellular carcinoma whose expression is regulated by miR-664a-3p, which is upregulated in HCC. In this study, we performed a battery of robust and systematic in silico analyses to predicate the possible lncRNA-miRNA interactions between MEG3, miR-664a-3p, and ADH4. miRNA-mRNA and lncRNA-miRNA hybrid structures were primarily obtained, and the minimum free energies (MFEs) for the 3'UTR (Untranslated Regions) of ADH4-miR-664a-3p and the 3'UTR of MEG3-miR-664a-3p interactions were assessed to predict the stability of the obtained RNA heteroduplex hybrids. The hybrid with the least minimum free energy (MFE) was considered to be the most favorable. The MFEs were around -28.1 kcal/mol and -31.3 kCal/mol for the ADH4-miR-664a-3p and MEG3-miR-66a-3p RNA hybrids, respectively. This demonstrated that lncRNA-MEG3 might be a competitive endogenous RNA that acts as a molecular sponge for miR-664a-3p. In summary, our interaction analyses results predict the significance of the MEG3/miR-664a-3p/ADH4 axis, where MEG3 downregulation results in miR-664a-3p overexpression and the subsequential underexpression of ADH4 in HCC, as a novel axis of interest that demands further validation. FAU - Karunakara, Shreyas H AU - Karunakara SH AD - Department of Biochemistry, Center of Excellence in Molecular Biology & Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore 570015, India. FAU - Puttahanumantharayappa, Lakshana D AU - Puttahanumantharayappa LD AD - Department of Biochemistry, Center of Excellence in Molecular Biology & Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore 570015, India. FAU - Sannappa Gowda, Nirmala G AU - Sannappa Gowda NG AD - Department of Biochemistry, Center of Excellence in Molecular Biology & Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore 570015, India. FAU - Shiragannavar, Varsha D AU - Shiragannavar VD AD - Department of Biochemistry, Center of Excellence in Molecular Biology & Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore 570015, India. FAU - Santhekadur, Prasanna K AU - Santhekadur PK AUID- ORCID: 0000-0003-3338-375X AD - Department of Biochemistry, Center of Excellence in Molecular Biology & Regenerative Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysore 570015, India. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20221130 PL - Switzerland TA - Genes (Basel) JT - Genes JID - 101551097 RN - 0 (3' Untranslated Regions) RN - EC 1.1.1.1 (alcohol dehydrogenase IV) RN - 0 (MicroRNAs) RN - 0 (Proteins) RN - 0 (RNA, Long Noncoding) RN - 0 (MEG3 non-coding RNA, human) RN - 0 (MIRN664 microRNA, human) SB - IM MH - Humans MH - 3' Untranslated Regions MH - *Carcinoma, Hepatocellular/pathology MH - *Liver Neoplasms/pathology MH - *MicroRNAs/metabolism MH - Proteins/genetics MH - *RNA, Long Noncoding/metabolism PMC - PMC9778073 OTO - NOTNLM OT - MEG3 OT - alcohol dehydrogenase 4 OT - hepatocellular carcinoma OT - mean binding energy OT - miR-664a-3p OT - tumor suppressor COIS- The authors declare no conflict of interest. EDAT- 2022/12/24 06:00 MHDA- 2022/12/27 06:00 PMCR- 2022/11/30 CRDT- 2022/12/23 01:22 PHST- 2022/10/21 00:00 [received] PHST- 2022/11/19 00:00 [revised] PHST- 2022/11/28 00:00 [accepted] PHST- 2022/12/23 01:22 [entrez] PHST- 2022/12/24 06:00 [pubmed] PHST- 2022/12/27 06:00 [medline] PHST- 2022/11/30 00:00 [pmc-release] AID - genes13122254 [pii] AID - genes-13-02254 [pii] AID - 10.3390/genes13122254 [doi] PST - epublish SO - Genes (Basel). 2022 Nov 30;13(12):2254. doi: 10.3390/genes13122254.